trending Market Intelligence /marketintelligence/en/news-insights/trending/hHHevAagqkmru1FkQR--RQ2 content esgSubNav
In This List

GT Biopharma's CFO resigns

Blog

Insight Weekly: Recession risk persists; Banks pull back from crypto; 2022 laggard stocks rally

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Blog

Insight Weekly: Inflation eases; bank M&A slows; top companies boost market share

Blog

Insight Weekly: PE firms shift strategies; bank earnings kick off; bankruptcies plummet


GT Biopharma's CFO resigns

GT Biopharma Inc. said Steven Weldon resigned as CFO and director of the company, effective Oct. 11.

The Westlake Village, Calif.-based developer of cancer therapies said that Weldon's resignation did not result from any disagreement with the company.